1. Home
  2. SSTK vs TSHA Comparison

SSTK vs TSHA Comparison

Compare SSTK & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSTK
  • TSHA
  • Stock Information
  • Founded
  • SSTK 2003
  • TSHA 2019
  • Country
  • SSTK United States
  • TSHA United States
  • Employees
  • SSTK N/A
  • TSHA N/A
  • Industry
  • SSTK EDP Services
  • TSHA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SSTK Technology
  • TSHA Health Care
  • Exchange
  • SSTK Nasdaq
  • TSHA Nasdaq
  • Market Cap
  • SSTK 668.4M
  • TSHA 728.4M
  • IPO Year
  • SSTK 2012
  • TSHA 2020
  • Fundamental
  • Price
  • SSTK $21.91
  • TSHA $3.00
  • Analyst Decision
  • SSTK Buy
  • TSHA Strong Buy
  • Analyst Count
  • SSTK 4
  • TSHA 7
  • Target Price
  • SSTK $43.67
  • TSHA $8.71
  • AVG Volume (30 Days)
  • SSTK 271.5K
  • TSHA 2.6M
  • Earning Date
  • SSTK 07-29-2025
  • TSHA 08-12-2025
  • Dividend Yield
  • SSTK 6.00%
  • TSHA N/A
  • EPS Growth
  • SSTK 38.48
  • TSHA N/A
  • EPS
  • SSTK 1.81
  • TSHA N/A
  • Revenue
  • SSTK $1,010,504,000.00
  • TSHA $8,098,000.00
  • Revenue This Year
  • SSTK $10.45
  • TSHA N/A
  • Revenue Next Year
  • SSTK $3.19
  • TSHA N/A
  • P/E Ratio
  • SSTK $12.13
  • TSHA N/A
  • Revenue Growth
  • SSTK 14.20
  • TSHA N/A
  • 52 Week Low
  • SSTK $14.35
  • TSHA $1.05
  • 52 Week High
  • SSTK $38.80
  • TSHA $3.31
  • Technical
  • Relative Strength Index (RSI)
  • SSTK 60.81
  • TSHA 63.38
  • Support Level
  • SSTK $20.92
  • TSHA $2.76
  • Resistance Level
  • SSTK $22.45
  • TSHA $3.05
  • Average True Range (ATR)
  • SSTK 0.96
  • TSHA 0.15
  • MACD
  • SSTK 0.08
  • TSHA 0.00
  • Stochastic Oscillator
  • SSTK 82.12
  • TSHA 75.51

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: